PmcKwd.i
Checkpoint
Pmc
Racine
Checkpoint
Pmc
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (Pmc)

Index « PmcKwd.i » - entrée « Remission »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Remdesivir < Remission < Remission Induction  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 6.
Ident.Authors (with country if any)Title
000084 (2020) Chayma Ladhari [France] ; Pierre Le Blay [France] ; Thierry Vincent [France] ; Ahmed Larbi [France] ; Emma Rubenstein [France] ; Rosanna Ferreira Lopez [France] ; Christian Jorgensen [France] ; Yves-Marie Pers [France]Successful long-term remission through tapering tocilizumab infusions: a single-center prospective study
000407 (2020) Takahiko Sugihara [Japon] ; Hitoshi Hasegawa ; Haruhito A. Uchida [Japon] ; Hajime Yoshifuji [Japon] ; Yoshiko Watanabe [Japon] ; Eisuke Amiya [Japon] ; Yasuhiro Maejima [Japon] ; Masanori Konishi [Japon] ; Yohko Murakawa [Japon] ; Noriyoshi Ogawa [Japon] ; Shunsuke Furuta [Japon] ; Yasuhiro Katsumata [Japon] ; Yoshinori Komagata [Japon] ; Taio Naniwa [Japon] ; Takahiro Okazaki [Japon] ; Yoshiya Tanaka [Japon] ; Tsutomu Takeuchi [Japon] ; Yoshikazu Nakaoka [Japon] ; Yoshihiro Arimura [Japon] ; Masayoshi Harigai [Japon] ; Mitsuaki Isobe [Japon]Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions
000588 (2019) Arata Nakajima [Japon] ; Keiichiro Terayama [Japon] ; Masato Sonobe [Japon] ; Yasuchika Aoki [Japon] ; Hiroshi Takahashi [Japon] ; Yorikazu Akatsu [Japon] ; Junya Saito [Japon] ; Shinji Taniguchi [Japon] ; Manabu Yamada [Japon] ; Ayako Kubota [Japon] ; Koichi Nakagawa [Japon]Serum levels of reactive oxygen metabolites at 12 weeks during tocilizumab therapy are predictive of 52 weeks-disease activity score-remission in patients with rheumatoid arthritis
000C43 (2018) Josef S. Smolen [Autriche] ; Annette Szumski [États-Unis] ; Andrew S. Koenig [États-Unis] ; Thomas V. Jones [États-Unis] ; Lisa Marshall [États-Unis]Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial
000D48 (2017) Sarah Salomon [France] ; Caroline Guignant [France] ; Pierre Morel [France] ; Gauthier Flahaut [France] ; Clément Brault [France] ; Clément Gourguechon [France] ; Patrice Fardellone [France] ; Jean-Pierre Marolleau [France] ; Brigitte Gubler [France] ; Vincent Goëb [France]Th17 and CD24hiCD27+ regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritis
000D49 (2017) Birgir Gudbrandsson [Norvège] ; Yvind Molberg [Norvège] ; Yvind Palm [Norvège]TNF inhibitors appear to inhibit disease progression and improve outcome in Takayasu arteritis; an observational, population-based time trend study

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Pmc/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/PmcKwd.i -k "Remission" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/PmcKwd.i  \
                -Sk "Remission" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Pmc
   |étape=   Checkpoint
   |type=    indexItem
   |index=    PmcKwd.i
   |clé=    Remission
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021